Thurman Wheeler

Title: Innovations and Contributions of Inventor Thurman Wheeler

Introduction

Thurman Wheeler is a notable inventor based in Rochester, NY (US), recognized for his significant contributions to the field of medical diagnostics and treatment. With a total of three patents to his name, Wheeler has made strides in understanding and addressing muscular dystrophies.

Latest Patents

One of his latest patents is titled "Extracellular mRNA markers of muscular dystrophies in human urine." This patent describes methods for diagnosing and monitoring subjects with diseases associated with aberrant splicing, based on detecting properly spliced isoforms and mis-spliced isoforms in a urine sample from the subject. Another important patent is "Modulation of dystrophia myotonica-protein kinase (DMPK) expression." This patent provides methods, compounds, and compositions for reducing the expression of DMPK mRNA and protein in an animal. It also includes methods for preferentially reducing CUGexp DMPK RNA, which can help treat, prevent, delay, or ameliorate type 1 myotonic dystrophy or its symptoms.

Career Highlights

Throughout his career, Thurman Wheeler has worked with prominent companies such as Ionis Pharmaceuticals, Inc. and The General Hospital Corporation. His work in these organizations has contributed to advancements in therapeutic approaches for muscular dystrophies.

Collaborations

Wheeler has collaborated with esteemed colleagues, including Charles A. Thornton and C. Frank Bennett, further enhancing the impact of his research and innovations.

Conclusion

Thurman Wheeler's contributions to the field of medical science through his patents and collaborations highlight his dedication to improving the lives of those affected by muscular dystrophies. His work continues to inspire advancements in diagnostics and treatment options.